12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cogane regulatory update

FDA granted Orphan Drug designation for Phytopharm's Cogane to treat amyotrophic lateral sclerosis. The...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >